U-100 Scale, SKU Identity & Procurement Controls
A practical guide for pharmacies, clinics, distributors and procurement teams that need to translate “U-100 insulin syringe” into an exact, documentable and fulfillment-ready purchasing specification.
Scope: This article is an institutional purchasing resource, not a dose-conversion tool or patient-specific instruction. The insulin concentration, syringe scale and approved configuration must match current drug labeling, prescriptions, organizational policy and qualified professional directions. Do not use this page to substitute syringe concentration scales or calculate an individual dose.
Quick answer
What Does U-100 Mean on an Insulin Syringe?
U-100 means the syringe barrel scale is designed to correspond to insulin labeled at 100 units per milliliter. It does not mean every U-100 insulin syringe has a 1 mL barrel or a 100-unit maximum. Common U-100 capacity categories include 0.3 mL, 0.5 mL and 1 mL, commonly associated with maximum markings of 30, 50 and 100 units respectively.
For healthcare buyers, U-100 is only the first product-identity field. A quote is not complete until it also fixes capacity, maximum marking, graduation interval, needle gauge and length, configuration, manufacturer REF, sterile presentation, package hierarchy, identifiers, shelf-life requirement and substitution rules.
Executive summary
Key Takeaways for Healthcare Buyers
- U-100 is a concentration-scale identity. It describes how the unit markings correspond to insulin at 100 units/mL; it does not define all other syringe attributes.
- U-100 and 100-unit capacity are not synonyms. Smaller U-100 barrels may have 30-unit or 50-unit maximum markings.
- Graduation is SKU-specific. Never assume that every syringe of the same capacity has the same interval or that every 0.3 mL product has half-unit markings.
- Gauge and needle length cannot identify the scale. The same needle dimensions may appear across several capacities, scales and configurations.
- Control the exact REF. Label, quotation, sample, purchase order, box, case and received product should reconcile to one approved identity.
- Do not authorize cross-concentration substitution. U-40, U-100 and U-500 are distinct systems; procurement should supply the matching approved device instead of relying on conversion.
- Compare supply programs after the SKU is frozen. Case price, MOQ, inventory and lead time are meaningful only when every supplier is quoting the same controlled specification.
1. U-100 Is a Scale Identity, Not a Complete Product Description
“U” refers to insulin units. A product labeled U-100 contains 100 units in each milliliter, and a matching U-100 syringe prints a unit scale intended for that concentration. In the correctly matched system, the barrel allows the prescribed number of insulin units to be read directly without treating the syringe as a generic milliliter-only device.
This definition explains why the same physical barrel capacity can carry a different concentration scale, and why a buyer should not approve a product from a photograph or needle-cap color alone. U-100 belongs beside the manufacturer, REF and labeling revision in the buyer’s product master data.
Procurement rule: Treat “U-100” as a non-substitutable product-identity field. Confirm it before capacity, needle size, packaging or price enters the comparison.
2. What U-100 Does—and Does Not—Tell a Buyer
| U-100 can identify | U-100 cannot identify by itself | Buyer verification |
|---|---|---|
| The concentration system represented by the unit scale | Whether the barrel is 0.3, 0.5 or 1 mL | Confirm nominal volume and maximum marking |
| That the scale is intended to correspond to 100 units/mL insulin | Whether adjacent lines represent half, one, two or another unit interval | Review the exact barrel artwork or controlled drawing |
| A critical concentration field for the approved SKU | Needle gauge, length, wall type or bevel | State gauge × length separately |
| A required catalog, PO and warehouse descriptor | Fixed needle, Luer, safety or other configuration | Verify actual structure and intended use |
| A basis for separating incompatible inventory | Sterility, barrier format, shelf life or latex statement | Request SKU-scoped label and evidence |
| A field that should be protected from substitution | Manufacturer, REF, UDI/GTIN, package quantity or market status | Reconcile the complete identity chain |
3. Is a U-100 Insulin Syringe Always 1 mL?
No. U-100 describes the concentration scale, while milliliters describe physical barrel capacity. The following table is a category-level purchasing snapshot, not a statement that every manufacturer’s markings, needle choices or package counts are identical.
| Nominal barrel capacity | Common U-100 maximum marking | What still requires exact-SKU verification |
|---|---|---|
| 0.3 mL / 0.3 cc | 30 units | Graduation interval, including whether a half-unit option is actually offered |
| 0.5 mL / 0.5 cc | 50 units | Graduation, gauge × length, sterile presentation and package quantity |
| 1 mL / 1 cc | 100 units | Graduation, configuration, intended use, manufacturer REF and packaging |
For a fuller comparison of barrel sizes, unit capacities, gauge and needle length, use Tonmit’s guide to compare 0.3 mL, 0.5 mL and 1 mL insulin syringe sizes. This article intentionally keeps the size discussion short so the U-100 page remains focused on identity and procurement control.
Two terms that buyers should not merge
U-100 insulin syringe identifies a concentration-calibrated syringe category. 100-unit insulin syringe usually points to the maximum marking of a 1 mL U-100 format. Search queries may use the phrases interchangeably, but purchase records should not.
4. How to Decode a Complete U-100 Insulin Syringe SKU
A professional RFQ should turn a generic search phrase into a field-by-field product identity. One practical structure is:
U-100 scale | 0.5 mL / 50-unit maximum | [verified graduation] | 31G
× 8 mm | fixed needle | sterile single-use | [primary pack] | 100/box
| [boxes]/case | manufacturer REF [____] | UDI/GTIN [____] | label
revision [____]
This is a field template, not a claim that every quoted product has these exact characteristics. Replace every bracketed field with the supplier’s controlled information and reconcile it across the specification, sample, label and commercial documents. Buyers ready to compare available programs can review wholesale insulin syringe options after approving the specification.
5. Why Graduation Must Be Verified by Exact REF
Capacity and graduation answer different questions. Capacity establishes how much the barrel can contain; graduation establishes what the interval between adjacent scale lines represents. A catalog may contain several U-100 products that share capacity but differ in graduation, needle dimensions or safety configuration.
Selected manufacturer portfolios illustrate this variation: a 0.3 mL family may include a half-unit-scale option, while other products use different scales or configurations.[1] That is evidence of product variation—not permission to generalize one SKU’s markings to every 0.3 mL syringe.
- Request the exact REF and current controlled product specification.
- Review a clear barrel-scale image or engineering artwork.
- Confirm the maximum marking and adjacent-line interval separately.
- Match the approved sample to the quote and packaging label.
- Record whether a special graduation is mandatory or merely preferred.
- Reject substitutions that change graduation without written approval.
Do not state “all 1 mL U-100 syringes use two-unit graduations” or “all 0.3 mL syringes use half-unit markings.” Those claims are too broad for SKU-controlled procurement.
6. U-100 vs U-40 and U-500: Prevent Cross-Concentration Substitution
U-40, U-100 and U-500 are different concentration systems. Needle gauge, barrel color or similar packaging does not make the scales interchangeable. FDA’s communication about the dedicated U-500 syringe explains that the U-500 vial label was updated to remove conversion information for U-100 and tuberculin syringes once the dedicated device became available.[2]
The purchasing response is straightforward: provide the concentration-matched, organization-approved device and prohibit unauthorized substitution. For the detailed concentration comparison and mismatch controls, review the differences between U-40 and U-100 insulin syringes.
Do not turn a purchasing guide into a conversion chart
This article intentionally does not provide U-40/U-100/U-500 dose-conversion tables. Mathematical conversion does not remove the selection, labeling, communication and administration risks created by a mismatched device.
Copy-ready PO control:
No substitution of concentration scale, barrel capacity, maximum unit marking, graduation interval, needle gauge, needle length, product configuration, legal manufacturer, manufacturing site, REF, sterile presentation, label, identifier or packaging revision without the buyer’s prior written approval.
7. Fixed-Needle, Safety and Luer Configurations Are Separate Decisions
“U-100” does not establish how the needle or connection is configured. Many familiar retail insulin syringes use an attached fixed needle, but safety insulin syringes have an actual protective mechanism and Luer configurations serve different connection and use pathways. A standard fixed-needle product must not be marketed as a safety syringe simply because it has a needle cap.
An FDA recall involving specified lots of a Monoject U-100 1 mL Luer-Lock syringe concerned incompatibility with needleless IV connectors.[3] The case is useful for one narrow procurement lesson: the words “U-100” and “1 mL” did not fully identify the configuration, intended use, REF or affected lots. It should not be generalized to ordinary fixed-needle U-100 syringes.
| Configuration field | Do not infer from | Required buyer evidence |
|---|---|---|
| Fixed needle | Product-family name or image angle | Specification, label and physical sample |
| Safety feature | Needle cap, orange shield or the word “secure” | Actual protective mechanism and applicable records |
| Luer connection | 1 mL capacity alone | Tip type, connection compatibility and intended-use information |
| Low dead space | Fixed needle alone | Defined design and applicable technical evidence |
| Latex statement | Clear barrel or packaging appearance | Current SKU-specific material statement |
8. Put U-100 Into Catalog, PO and Warehouse Controls
U-100 should be visible wherever staff make a selection, substitution, receiving or traceability decision. Hiding the scale in a long description while the short title reads only “insulin syringe 31G” creates avoidable ambiguity.
Master specification and sample
PO with no-substitution rule
REF, lot, expiry and count
Separated and labeled inventory
Outbound orders and monitoring
| Record or location | Minimum U-100 control | Common failure |
|---|---|---|
| RFQ and quotation | Scale plus the complete requested or offered REF | Supplier quotes an “equivalent” family without differences |
| Approved specification | Scale, capacity, graduation, needle, configuration and pack | Only a catalog screenshot is approved |
| ERP/catalog title | U-100, capacity, gauge × length, manufacturer and REF | Title shows only gauge or box count |
| Purchase order | Exact identifiers, revision, quantities and substitution restriction | PO uses a generic free-text description |
| Warehouse location | Concentration-visible bin label and separated stock | Similar packages share an ambiguous pick face |
| Receiving record | REF, label revision, lot, expiration and accepted quantity | Only case quantity is recorded |
| Complaint or recall file | Lot-to-location and lot-to-customer traceability | Affected outbound orders cannot be identified quickly |
9. Verify U-100 Product Claims With Evidence, Not Catalog Language
A supplier statement becomes useful only when the buyer can identify the exact product and the evidence supporting it. Request SKU-specific medical device documentation support instead of asking for an undifferentiated folder of certificates.
| Supplier statement | Evidence to request | Do not accept as a substitute |
|---|---|---|
| U-100 scale | Current label, barrel artwork, specification and exact REF | A generic family photo |
| Half-unit markings | Controlled scale drawing and approved sample | Assumption based on 0.3 mL capacity |
| Sterile | SKU label, sterile-barrier specification and applicable process records | A certificate for a different product or site |
| Safety syringe | Actual safety mechanism and applicable product record | A protective cap on a non-safety syringe |
| Latex-related claim | Current material statement tied to the SKU | Packaging color or an unrelated brochure |
| Shelf life | Applicable labeling and shelf-life basis for the product and pack | A uniform promise across all SKUs |
| U.S. inventory | Available REF, lot, expiration, releasable quantity and status date | Warehouse address alone |
| 100 per box | Unit-to-box-to-case hierarchy in quote and labels | A retail-box image without master-case data |
10. Box, Case, Shelf-Life and Landed-Cost Controls
“100 syringes per box” does not establish how many boxes are in a case, whether units are bagged or individually presented, or how freight should be compared. Record each packaging level and calculate commercial terms against the accepted-syringe count.
Case quantity = syringes per box × boxes per case
Accepted-syringe cost = total landed program cost ÷ syringes accepted after receiving inspection
Usable inventory horizon depends on remaining shelf life at receipt, expected demand, replenishment time and the buyer’s inventory policy.
Total landed program cost can include product, packaging, freight, duty, brokerage, warehousing, domestic delivery, inspection, rejected goods, shortage management and administrative work. Use the guide to calculate insulin syringe case quantities and landed cost after locking the exact U-100 SKU.
Private-label programs introduce additional artwork, identifier, role and change-control questions. Buyers considering branded packaging should separately review private-label insulin syringe requirements rather than treating a logo change as a purely graphic task.
11. Regulatory and Quality Documentation Must Match the Exact Product
FDA states that it does not issue registration certificates to medical-device facilities and that registration and listing do not by themselves denote approval, clearance or authorization.[4] For U.S. procurement, a screenshot headed “FDA registered” is therefore not a complete product review.
FDA’s classification database identifies piston syringes under product code FMF and 21 CFR 880.5860 as Class II devices with 510(k) submission type.[5] FDA’s Quality Management System Regulation became effective on February 2, 2026 and incorporates ISO 13485:2016 by reference while retaining applicable FDA requirements.[6]
A buyer’s documentation matrix may therefore include the legal manufacturer and site, product classification, applicable premarket record, establishment and listing information, UDI/GUDID information where applicable, current U.S. labeling, quality-system scope, sterile-product evidence, shelf-life information, change control and lot traceability. Applicability must be determined for the exact SKU, entities, market and transaction.
Record the relationship, not merely the document name
For each item, record the organization named, site, product or model scope, REF relationship, version or validity date, reviewer, public database search date and unresolved mismatch. A current document for the wrong product is still the wrong evidence.
12. U.S. Inventory and Replenishment Questions
A U.S. warehouse can support faster replenishment, but location alone does not prove that the approved REF is available, released, within the required shelf-life window or traceable. Ask for a dated availability response for the exact SKU.
- Which exact manufacturer REF and package revision are currently available?
- What quantity is released and allocable rather than merely inbound?
- Which lots and expiration dates would be supplied?
- What minimum remaining shelf life will be guaranteed at receipt?
- Can inventory be reserved, and for how long?
- What are domestic dispatch time, freight terms and delivery scope?
- What is the replenishment plan when local inventory falls below the reorder point?
- How are backorders, partial shipments and substitutions communicated?
- Can affected lots be located across stored and shipped inventory?
Tonmit’s U.S.-warehouse-supported fulfillment overview explains how availability, replenishment and domestic coordination should be reviewed as a supply program. For a broader vendor decision, use the framework to evaluate a wholesale insulin syringe supplier.
13. Copyable U-100 Insulin Syringe RFQ
Send the same field structure to every candidate. If a field is undecided, mark it “buyer review required” instead of allowing the supplier to silently choose.
Product: U-100 insulin syringe for [approved institutional or distribution use]
Barrel capacity / maximum marking: [0.3 mL / 30 units] [0.5 mL / 50 units] [1 mL / 100 units] [other approved requirement]
Graduation interval: [exact requirement—do not infer from capacity]
Needle: [gauge] × [length in mm and inch] | [wall type if required]
Configuration: [fixed needle / verified safety configuration / other approved type]
Presentation: sterile, single-use | [individual pack or bag requirement] | [material statements required]
Identity: legal manufacturer | manufacturing site | manufacturer REF | brand SKU | UDI/GTIN where applicable | label revision
Packaging: syringes/primary pack | syringes/box | boxes/case | case dimensions and weight | pallet quantity if applicable
Documentation: product specification | current labels | applicable regulatory identity summary | quality-system information | sterile-product and shelf-life records | lot/traceability document list
Commercial: standard MOQ | private-label MOQ if applicable | unit, box and case price | Incoterm | freight basis | tooling/artwork fees | payment terms
Supply: production lead time | current U.S. inventory by exact REF | lot and expiry offered | minimum remaining shelf life | replenishment method
Sample: exact production-equivalent REF, package and label required before approval
Substitution: no change to any controlled field without prior written buyer approval
14. Frequently Asked Questions
What does U-100 mean on an insulin syringe?
U-100 means the barrel’s insulin-unit scale corresponds to insulin labeled at 100 units per milliliter. It identifies the concentration scale, not every other syringe specification.
Is a U-100 insulin syringe always 1 mL?
No. Common U-100 categories include 0.3 mL, 0.5 mL and 1 mL. Capacity and concentration scale must be recorded as separate product fields.
Does U-100 mean the syringe holds 100 units?
Not necessarily. A 1 mL U-100 format commonly has a 100-unit maximum, while common 0.3 mL and 0.5 mL U-100 categories have 30-unit and 50-unit maximum markings.
Is 1 cc the same volume as 1 mL?
Yes, 1 cc and 1 mL express the same volume. That volume equivalence does not identify the insulin concentration scale, graduation or exact syringe SKU.
Does every U-100 syringe use the same graduation?
No. Graduation must be verified from the exact REF, controlled scale drawing, current label and sample. Do not generalize a graduation from capacity alone.
Can gauge identify whether a syringe is U-100?
No. Gauge describes relative needle diameter. The same gauge and length may appear on different capacities, concentration scales and configurations.
Can U-40, U-100 and U-500 syringes be substituted?
They should not be treated as interchangeable. Supply the concentration-matched device required by current labeling, prescriptions, organizational approval and qualified professional directions.
What should be included in a wholesale U-100 insulin syringe RFQ?
Include scale, capacity, maximum marking, graduation, gauge × length, configuration, sterile presentation, manufacturer and REF, identifiers, package hierarchy, required documents, shelf-life requirement, quantity, destination, commercial terms and a no-substitution rule.
What should buyers check when a bulk order arrives?
Verify the manufacturer, REF, U-100 label, capacity, graduation, gauge × length, configuration, pack revision, quantity, lot, expiration, sterile-barrier condition and required transaction records against the approved PO.
15. From “U-100 Syringes” to a Controlled Purchasing Specification
U-100 is simple to define but incomplete as a purchasing description. It identifies the insulin concentration system represented by the barrel scale; it does not establish capacity, graduation, needle, configuration, package, evidence or supply terms.
The useful procurement outcome is a controlled identity chain:
U-100 scale → capacity and maximum marking → graduation → needle and configuration → legal manufacturer and REF → label and package revision → lot and expiration → approved supply terms.
Once that chain is fixed, healthcare buyers can compare bulk U-100 insulin syringe supply, case economics, documentation and replenishment without allowing price or appearance to conceal a product difference.
Specification & supply review
Request a U-100 Insulin Syringe SKU Review
Share the required U-100 capacity, graduation, gauge × length, packaging, destination market, estimated quantity and document checklist. Tonmit can help review applicable product options, available documentation, bulk terms and U.S.-warehouse-supported fulfillment for the selected program.
Availability, documentation, labeling, MOQ, inventory and delivery terms must be confirmed for the exact SKU and transaction.References
- embecta / BD. BD SafetyGlide insulin syringe product overview. Product examples show multiple barrel capacities and a selected 0.3 mL half-unit-scale configuration. Accessed August 6, 2026.
- U.S. Food and Drug Administration. FDA approves a dedicated syringe to be used with Humulin R U-500 insulin. Accessed August 6, 2026.
- U.S. Food and Drug Administration. Recall of certain Monoject U-100 1 mL insulin syringe Luer-Lock lots. The cited event is configuration- and lot-specific. Accessed August 6, 2026.
- U.S. Food and Drug Administration. Important Reminders about Registration and Listing. Accessed August 6, 2026.
- U.S. Food and Drug Administration. Product Classification: Syringe, Piston (FMF). Accessed August 6, 2026.
- U.S. Food and Drug Administration. Quality Management System Regulation (QMSR). Accessed August 6, 2026.
